DCC-2036

CAT: 1410-M10095-01Size: 1 gDry Ice: NoHazardous: No
CAT#:1410-M10095-01Size:1 g
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.
CAS Number
1020172-07-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
553.5869
Molecular Formula
C30H28FN7O3
Notes
Research use only, not for human use.
Receptor
Abl1|FLT3|p-Abl1 (native) |p-Abl1 (T315I) |u-Abl1 (native)

Popular Products